7-hydroxy-indolinyl antagonists of P2Y1 receptor
US9540323B2 · kind B2 · utility
0Cited by
3References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 30, 2013 |
| Grant date | Jan 10, 2017 |
| Priority date | — |
| Expiry date | Jul 30, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds of Formula (I): Formula (I) as defined in the specification and compositions comprising any of such novel compounds. These compounds are antagonists of P2Y1 receptor which may be used medicaments.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.